Nanalysis Scientific (CVE:NSCI) Reaches New 52-Week Low – Should You Sell?

Nanalysis Scientific Corp. (CVE:NSCI) shares reached a new 52-week low on Wednesday . The stock traded as low as C$0.14 and last traded at C$0.14, with a volume of 4879 shares traded. The stock had previously closed at C$0.15.

Nanalysis Scientific Stock Down 3.4%

The firm has a market cap of C$16.08 million, a price-to-earnings ratio of -1.40 and a beta of -0.75. The business’s 50-day moving average is C$0.16 and its 200-day moving average is C$0.17. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42.

About Nanalysis Scientific

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.